Case File
efta-02024345DOJ Data Set 10OtherEFTA02024345
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-02024345
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
jeeyacationtagmail.com[[email protected]]; Jeffrey [email protected]]
From:
Rich Kahn
Sent:
Mon 3/28/2011 1:38:48 PM
Subject: Reminders
a)
Wire — see below
b) Erica — regarding LS.I LLC (Delaware vs. usvi) and rule that allows US companies to move to USVI
Rich Kahn
HBRK Associates Inc.
301 East 66th Street, Suite 10F
New York, NY 10065
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Wednesday, March 23, 2011 9:22 AM
To: Rich Kahn
Subject: Re: No subject
remind me on mon
2011/3/23 Rich Kahn c
al>
Should I wire funds?
If so what amount? S US Dollars?
Rich Kahn
HBRK Associates Inc.
EFTA_R1_00531207
EFTA02024345
301 East 66th Street, Suite 10F
New York, NY 10065
From: Jeffrey Epstein [maitto:[email protected]]
Sent: Wednesday, March 23, 2011 8:51 AM
To: Rich Kahn
Subject: Fwd: No subject
Faormwarded message
From:
AJIHHa
Date: 2011/3/22
Subject: Re: No subject
To: Jeffrey Epstein <[email protected]>
Beneficiary:
Account numbc
Beneficiary's bank: Open Joint Stock Company Raiiffeisen BANK AVAL, Kiev, Ukraine
SWIFT code
Correspondent bank: Acc.
Raiffeisen Zentralbank Oesterreich, Vienna
SWIFT code
***********************************************************
The information contained in this communication is
EFTA_R1_00531208
EFTA02024346
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacationOgmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00531 209
EFTA02024347
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jeevacationogmail.comDomain
jeeyacationtagmail.comEmail
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.